Atossa Therapeutics, Inc. (ATOS) financial statements (2022 and earlier)

Company profile

Business Address 107 SPRING STREET
SEATTLE, WA 98104
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments136,37739,55412,58110,3807,2173,028
Cash and cash equivalents136,37739,55412,58110,3807,2173,028
Restricted cash and investments1101101101105555
Receivables    358 
Prepaid expense2,4881,814862510251172
Other current assets1,193658263116 
Other undisclosed current assets1,072635740518  
Total current assets:141,24042,77014,31911,5497,8983,255
Noncurrent Assets
Operating lease, right-of-use asset 1850
Property, plant and equipment202134541155
Intangible assets, net (including goodwill)    76640
Intangible assets, net (excluding goodwill)    76640
Other noncurrent assets2171717179194
Other undisclosed noncurrent assets 136999  
Total noncurrent assets:2269171171266890
TOTAL ASSETS:141,26242,83914,49011,7208,1644,144
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1052,6461,2701,4651,2101,041
Accounts payable1,7171,589293353335254
Accrued liabilities20493781779017
Employee-related liabilities1,184964899935785770
Debt  39   
Deferred compensation liability   1,410  
Other liabilities2151340166
Other undisclosed current liabilities 13,021    
Total current liabilities:3,12615,6721,3232,9151,2251,047
Noncurrent Liabilities
Long-term debt and lease obligation  11   
Operating lease, liability  11
Total noncurrent liabilities:  11   
Total liabilities:3,12615,6721,3342,9151,2251,047
Stockholders' equity
Stockholders' equity attributable to parent, including:138,13627,16813,1568,8056,9393,097
Preferred stock 000  
Common stock22,7928,5591,6441,05247757
Additional paid in capital243,996129,887105,58384,58471,88860,344
Accumulated deficit(129,234)(111,899)(94,071)(76,831)(65,426)(57,304)
Other undisclosed stockholders' equity attributable to parent582621    
Total stockholders' equity:138,13627,16813,1568,8056,9393,097
TOTAL LIABILITIES AND EQUITY:141,26242,83914,49011,7208,1644,144

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Operating expenses(20,521)(14,607)(17,265)(11,434)(7,649)(7,969)
Operating loss:(20,521)(14,607)(17,265)(11,434)(7,649)(7,969)
Nonoperating income (expense)(85)51262901,600
Investment income, nonoperating    (18)(163)
Other nonoperating income (expense)(85)512629  
Interest and debt expense    (79)(43)
Other undisclosed loss from continuing operations before equity method investments, income taxes    (394) 
Loss from continuing operations before equity method investments, income taxes:(20,606)(14,557)(17,240)(11,405)(8,123)(6,412)
Other undisclosed income (loss) from continuing operations before income taxes (3,271)   43
Net loss attributable to parent:(20,606)(17,828)(17,240)(11,405)(8,123)(6,369)
Preferred stock dividends and other adjustments    (2,568) 
Other undisclosed net loss available to common stockholders, basic (4,503) (11,479)  
Net loss available to common stockholders, diluted:(20,606)(22,331)(17,240)(22,884)(10,691)(6,369)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(20,606)(17,828)(17,240)(11,405)(8,123)(6,369)
Comprehensive loss, net of tax, attributable to parent:(20,606)(17,828)(17,240)(11,405)(8,123)(6,369)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: